| 1 |
29214842 | Trastuzumab emtansine: determining its role in management of HER2+ breast cancer. | 2018 Mar |
1 |
| 2 |
27174129 | Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates. | 2016 Jul 20 |
3 |
| 3 |
25738231 | Maytansinoid-BODIPY Conjugates: Application to Microscale Determination of Drug Extinction Coefficients and for Quantification of Maytansinoid Analytes. | 2015 Jun 1 |
1 |
| 4 |
21391620 | Design of antibody-maytansinoid conjugates allows for efficient detoxification via liver metabolism. | 2011 Apr 20 |
4 |
| 5 |
21481526 | Antibody-DM1 conjugates as cancer therapeutics. | 2011 Aug 28 |
1 |
| 6 |
20421541 | Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer. | 2010 Jun 1 |
3 |
| 7 |
16081651 | Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry. | 2005 Sep |
1 |